Related Experiment Video
Updated: Aug 30, 2026

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
Polyglutamines stop traffic: axonal transport as a common target in neurodegenerative diseases
Mel B Feany1, Albert R La Spada
1Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.
Abstract:
In this issue of Neuron, two papers provide evidence that polyglutamine (polyQ) proteins disrupt axonal transport. Gunawardena et al. show that normal levels of huntingtin are required for proper axonal transport in Drosophila. In addition, expression of expanded polyQ proteins disrupts axonal transport in larval neurons. Szebenyi and colleagues find that polyQ proteins directly inhibit fast axonal transport using axoplasm from the squid giant axon and suggest that axonal transport defects may be a common feature of polyQ disease pathogenesis.
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Alzheimer's Disease: Treatment
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction

